Lv11
40 积分 2025-03-20 加入
Case Series: Effectiveness and Safety of Telitacicept in Chinese Patients With Primary Sjögren's Disease
1个月前
已完结
Case Report: A case of membranous nephropathy associated with primary Sjögren’s syndrome treated with telitacicept
1个月前
已完结
Update on infections and vaccinations in systemic lupus erythematosus and Sjögren's syndrome
1个月前
已完结
ELABELA衍生肽ELA13通过抑制Smad和ERK信号通路减轻肾纤维化
4个月前
已完结
Update on the pathophysiology and treatment of primary Sjögren syndrome
5个月前
已完结
Dietary-timing-induced gut microbiota diurnal oscillations modulate inflammatory rhythms in rheumatoid arthritis
8个月前
已完结
The gut microbiome as a potential therapeutic target in IgA nephropathy
8个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
8个月前
已完结
Efficacy and Safety of Nefecon in Patients with Immunoglobulin A Nephropathy from Mainland China: 2-Year NefIgArd Trial Results
8个月前
已完结
Successful pregnancy in a patient with IgA nephropathy treated with telitacicept: a case report
8个月前
已关闭
皖公网安备34019202002308
